Trial Profile
The Observation Of Safety And Survival Of Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Combined With Anti-hepatitis B Virus Therapy.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Telbivudine (Primary) ; Antineoplastics
- Indications Hepatitis B; Liver cancer
- Focus Adverse reactions
- 15 Apr 2010 New trial record